Home/Filings/4/0001140361-25-020669
4//SEC Filing

Zhang Ping 4

Accession 0001140361-25-020669

CIK 0001124105other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 6:13 PM ET

Size

5.4 KB

Accession

0001140361-25-020669

Insider Transaction Report

Form 4
Period: 2025-05-27
Zhang Ping
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-27+250,000250,000 total
    Exercise: $10.18Exp: 2035-05-27Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0002050176

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:13 PM ET
Size
5.4 KB